CBAY

Cymabay Therapeutics

Delisted

CBAY was delisted on the 21st of March, 2024.

100 hedge funds and large institutions have $218M invested in Cymabay Therapeutics in 2022 Q3 according to their latest regulatory filings, with 12 funds opening new positions, 18 increasing their positions, 30 reducing their positions, and 18 closing their positions.

Holders
100
Holders Change
-6
Holders Change %
-5.66%
% of All Funds
1.73%
Holding in Top 10
6
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.1%
New
12
Increased
18
Reduced
30
Closed
18
Calls
$865K
Puts
$520K
Net Calls
+$345K
Net Calls Change
-$111K
Name Market Value Shares Shares
Change
Shares
Change %
Acadian Asset Management
101
Acadian Asset Management
Massachusetts
-31,827 Closed
CM
102
Caption Management
Oklahoma
-30,000 Closed
MAMU
103
Myriad Asset Management US
Florida
-30,000 Closed
Rafferty Asset Management
104
Rafferty Asset Management
New York
-27,810 Closed
YIH
105
Y-Intercept (HK)
Hong Kong
-23,644 Closed
CHAM
106
Clear Harbor Asset Management
Connecticut
-15,600 Closed
BFM
107
Boothbay Fund Management
New York
-14,479 Closed
ECM
108
ExodusPoint Capital Management
New York
-13,535 Closed
Marshall Wace
109
Marshall Wace
United Kingdom
-11,000 Closed
VRM
110
Vectors Research Management
New York
-6,000 Closed
CAPTRUST Financial Advisors
111
CAPTRUST Financial Advisors
North Carolina
-5,628 Closed
New York State Common Retirement Fund
112
New York State Common Retirement Fund
New York
-584 Closed
HR
113
Howe & Rusling
New York
-200 Closed
TCM
114
Tradewinds Capital Management
Washington
-35 Closed
PA
115
Parallel Advisors
California
$0 1
AWM
116
Activest Wealth Management
Florida
$0 69
GWS
117
Glassman Wealth Services
Virginia
$0 1
Simplex Trading
118
Simplex Trading
Illinois
CFGS
119
Concourse Financial Group Securities
Alabama
MIM
120
Macroview Investment Management
Maryland
$0 1 +1 New